FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Kozel

Research Profile

Living Beings

Chemicals & Drugs

Physiology

Disorders

Cryptococcosis

Concepts & Ideas

Kinetics

Anatomy

Co-author Network

Publications

TOP 3
Mark A Hubbard; Peter Thorkildson; William H Welch; Thomas R Kozel
Stereo-selective binding of monoclonal antibodies to the poly-gamma-d-glutamic acid capsular antigen of Bacillus anthracis.
Maria Hovenden; Mark A Hubbard; David AuCoin; Julie Lovchik; C Rick Lyons; Dana E Reed; Peter Thorkildson; William H Welch; Thomas R Kozel
IgG Subclass and Heavy Chain Domains Contribute to Binding and Protection by mAbs to the Poly γ-D-glutamic Acid Capsular Antigen of Bacillus anthracis.
Marcellene A Gates-Hollingsworth; Thomas R Kozel
Serotype sensitivity of a lateral flow immunoassay for cryptococcal antigen.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Kozel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Mark A Hubbard; Peter Thorkildson; William H Welch; Thomas R Kozel
Stereo-selective binding of monoclonal antibodies to the poly-gamma-d-glutamic acid capsular antigen of Bacillus anthracis.
Molecular immunology 2013;55(3-4):337-44.
2013: Maria Hovenden; Mark A Hubbard; David AuCoin; Julie Lovchik; C Rick Lyons; Dana E Reed; Peter Thorkildson; William H Welch; Thomas R Kozel
IgG Subclass and Heavy Chain Domains Contribute to Binding and Protection by mAbs to the Poly γ-D-glutamic Acid Capsular Antigen of Bacillus anthracis.
PLoS pathogens 2013;9(4):e1003306.
2013: Marcellene A Gates-Hollingsworth; Thomas R Kozel
Serotype sensitivity of a lateral flow immunoassay for cryptococcal antigen.
Clinical and vaccine immunology : CVI 2013;20(4):634-5.
2013: M Piccioni; Donatella Pietrella; Francesco Bistoni; E Gabrielli; S Kenno; Thomas R Kozel; Claudia Monari; Eva Pericolini; Stefano Perito; Anna Vecchiarelli
A purified capsular polysaccharide markedly inhibits inflammatory response during endotoxic shock.
Infection and immunity 2013;81(1):90-8.
2012: Thomas R Kozel; Sean K Bauman
CrAg lateral flow assay for cryptococcosis.
Expert opinion on medical diagnostics 2012;6(3):245-51.
2012: David AuCoin; Richard A Bowen; Barbara M Judy; Nicole L Marlenee; Dana E Reed; Peter Thorkildson; Alfredo G Torres; Thomas R Kozel
Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei.
PloS one 2012;7(4):e35386.
2011: Dana E Nuti; Sharon J Peacock; Terry Wu; D Huw Davies; Richard Bowen; Paul J Brett; Mary N Burtnick; Narisara Chantratita; Reva B Crump; Farida Dwi Handayani; Philip L Felgner; Thomas R Kozel; C Rick Lyons; David P AuCoin
Identification of circulating bacterial antigens by in vivo microbial antigen discovery.
mBio 2011;2(4):.
2010: Gayle M Boxx; Thomas R Kozel; Casey T Nishiya; Mason X Zhang
Influence of mannan and glucan on complement activation and C3 binding by Candida albicans.
Infection and immunity 2010;78(3):1250-9.
2010: David P AuCoin; Reva B Crump; Peter Thorkildson; Dana E Nuti; John J LiPuma; Thomas R Kozel
Identification of Burkholderia cepacia complex bacteria with a lipopolysaccharide-specific monoclonal antibody.
Journal of medical microbiology 2010;59(Pt 1):41-7.
2009: Marcellene A Gates-Hollingsworth; Thomas R Kozel
Phenotypic heterogeneity in expression of epitopes in the Cryptococcus neoformans capsule.
Molecular microbiology 2009;74(1):126-38.
2009: Claudia Monari; Sara Bevilacqua; Miranda Piccioni; Eva Pericolini; Stefano Perito; Mario Calvitti; Francesco Bistoni; Thomas R Kozel; Anna Vecchiarelli
A microbial polysaccharide reduces the severity of rheumatoid arthritis by influencing Th17 differentiation and proinflammatory cytokines production.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(1):191-200.
2009: David AuCoin; Marjorie D Sutherland; Ann L Percival; C Rick Lyons; Julie Lovchik; Thomas R Kozel
Rapid detection of the poly-gamma-D-glutamic acid capsular antigen of Bacillus anthracis by latex agglutination.
Diagnostic microbiology and infectious disease 2009;64(2):229-32.
2009: Haijun Tian; Sarah Weber; Peter Thorkildson; Thomas R Kozel; Liise-anne Pirofski
Efficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice.
Infection and immunity 2009;77(4):1502-13.
2009: Gayle M Boxx; Casey T Nishiya; Thomas R Kozel; Mason X Zhang
Characteristics of Fc-independent human antimannan antibody-mediated alternative pathway initiation of C3 deposition to Candida albicans.
Molecular immunology 2009;46(3):473-80.
2008: Claudia Monari; Francesca Paganelli; Francesco Bistoni; Thomas R Kozel; Anna Vecchiarelli
Capsular polysaccharide induction of apoptosis by intrinsic and extrinsic mechanisms.
Cellular microbiology 2008;10(10):2129-37.
2008: Marjorie D Sutherland; Peter Thorkildson; Samuel D Parks; Thomas R Kozel
In vivo fate and distribution of poly-gamma-D-glutamic acid, the capsular antigen from Bacillus anthracis.
Infection and immunity 2008;76(3):899-906.
2007: Qing Zhou; Ruth A Gault; Thomas R Kozel; William Murphy
Protection from direct cerebral cryptococcus infection by interferon-gamma-dependent activation of microglial cells.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(9):5753-61.
2007: Thomas R Kozel; Peter Thorkildson; Suzanne Brandt; William H Welch; Julie Lovchik; David AuCoin; Julpohng Vilai; C Rick Lyons
Protective and immunochemical activities of monoclonal antibodies reactive with the Bacillus anthracis polypeptide capsule.
Infection and immunity 2007;75(1):152-63.
2006: Claudia Monari; Thomas R Kozel; Francesca Paganelli; Eva Pericolini; Stefano Perito; Francesco Bistoni; Arturo Casadevall; Anna Vecchiarelli
Microbial immune suppression mediated by direct engagement of inhibitory Fc receptor.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(10):6842-51.
2006: Marcellene A Gates; Thomas R Kozel
Differential localization of complement component 3 within the capsular matrix of Cryptococcus neoformans.
Infection and immunity 2006;74(6):3096-106.
2006: Joseph B Lillegard; Robert B Sim; Peter Thorkildson; Marcellene A Gates; Thomas R Kozel
Recognition of Candida albicans by mannan-binding lectin in vitro and in vivo.
The Journal of infectious diseases 2006;193(11):1589-97.
2006: Qing Zhou; Ruth A Gault; Thomas R Kozel; William Murphy
Immunomodulation with CD40 stimulation and interleukin-2 protects mice from disseminated cryptococcosis.
Infection and immunity 2006;74(4):2161-8.
2006: Mason X Zhang; M Charlotte Bohlman; Carol Itatani; Dennis R Burton; Paul W H I Parren; Stephen C St Jeor; Thomas R Kozel
Human recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated candidiasis in mice.
Infection and immunity 2006;74(1):362-9.
2006: Zong Liang Chang; Dale Netski; Peter Thorkildson; Thomas R Kozel
Binding and internalization of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, by murine peritoneal macrophages.
Infection and immunity 2006;74(1):144-51.
2005: Claudia Monari; Eva Pericolini; Giovanni Bistoni; Arturo Casadevall; Thomas R Kozel; Anna Vecchiarelli
Cryptococcus neoformans capsular glucuronoxylomannan induces expression of fas ligand in macrophages.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(6):3461-8.
2005: Claudia Monari; Francesco Bistoni; Arturo Casadevall; Eva Pericolini; Donatella Pietrella; Thomas R Kozel; Anna Vecchiarelli
Glucuronoxylomannan, a microbial compound, regulates expression of costimulatory molecules and production of cytokines in macrophages.
The Journal of infectious diseases 2005;191(1):127-37.
2005: Varough M Deyde; Albert A Rizvanov; Elmer W Otteson; Suzanne Brandt; Mariana Bego; Gregory S Pari; Thomas R Kozel; Sachiko T St Jeor
Identification of a monoclonal antibody from Peromyscus maniculatus (deer mouse) cytomegalovirus (PCMV) which binds to a protein with homology to the human CMV matrix protein HCMV pp71.
Journal of virological methods 2005;123(1):9-15.
2004: Luciana Tissi; Manuela Puliti; Francesco Bistoni; Paolo Mosci; Thomas R Kozel; Anna Vecchiarelli
Glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, inhibits the progression of group B streptococcal arthritis.
Infection and immunity 2004;72(11):6367-72.
2004: Thomas R Kozel; William Murphy; Suzanne Brandt; Bruce R Blazar; Julie Lovchik; Peter Thorkildson; Ann Percival; C Rick Lyons
mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(14):5042-7.
2004: Marcellene A Gates; Peter Thorkildson; Thomas R Kozel
Molecular architecture of the Cryptococcus neoformans capsule.
Molecular microbiology 2004;52(1):13-24.
2004: Thomas R Kozel; Randall S MacGill; Ann Percival; Qing Zhou
Biological activities of naturally occurring antibodies reactive with Candida albicans mannan.
Infection and immunity 2004;72(1):209-18.
2003: Suzanne Brandt; Peter Thorkildson; Thomas R Kozel
Monoclonal antibodies reactive with immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans.
Clinical and diagnostic laboratory immunology 2003;10(5):903-9.
2003: Thomas R Kozel; Stuart M Levitz; Françoise Dromer; Marcellene A Gates; Peter Thorkildson; Guilhem Janbon
Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains.
Infection and immunity 2003;71(5):2868-75.
2003: Claudia Monari; Cinzia Retini; Arturo Casadevall; Dale Netski; Francesco Bistoni; Thomas R Kozel; Anna Vecchiarelli
Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils.
European journal of immunology 2003;33(4):1041-51.
2003: Raymond M Duro; Dale Netski; Peter Thorkildson; Thomas R Kozel
Contribution of epitope specificity to the binding of monoclonal antibodies to the capsule of Cryptococcus neoformans and the soluble form of its major polysaccharide, glucuronoxylomannan.
Clinical and diagnostic laboratory immunology 2003;10(2):252-8.
2002: Claudia Monari; Thomas R Kozel; Francesco Bistoni; Anna Vecchiarelli
Modulation of C5aR expression on human neutrophils by encapsulated and acapsular Cryptococcus neoformans.
Infection and immunity 2002;70(7):3363-70.
2002: Anna Vecchiarelli; Donatella Pietrella; Francesco Bistoni; Thomas R Kozel; Arturo Casadevall
Antibody to Cryptococcus neoformans capsular glucuronoxylomannan promotes expression of interleukin-12Rbeta2 subunit on human T cells in vitro through effects mediated by antigen-presenting cells.
Immunology 2002;106(2):267-72.
2002: Dale Netski; Thomas R Kozel
Fc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificity.
Infection and immunity 2002;70(6):2812-9.
2002: A L Rosas; Randall S MacGill; Joshua D Nosanchuk; Thomas R Kozel; Arturo Casadevall
Activation of the alternative complement pathway by fungal melanins.
Clinical and diagnostic laboratory immunology 2002;9(1):144-8.
2001: Mason X Zhang; T Tristan Brandhorst; Thomas R Kozel; Bruce S Klein
Role of glucan and surface protein BAD1 in complement activation by Blastomyces dermatitidis yeast.
Infection and immunity 2001;69(12):7559-64.
2001: Cinzia Retini; Thomas R Kozel; Donatella Pietrella; Claudia Monari; Francesco Bistoni; Anna Vecchiarelli
Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans.
Infection and immunity 2001;69(10):6064-73.
2001: M Grinsell; LC Weinhold; Jim E Cutler; Y Han; Thomas R Kozel
In vivo clearance of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans: a critical role for tissue macrophages.
The Journal of infectious diseases 2001;184(4):479-87.
2001: Y Han; Thomas R Kozel; Mason X Zhang; Randall S MacGill; M C Carroll; Jim E Cutler
Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(3):1550-7.
2001: T C MacGill; Randall S MacGill; Thomas R Kozel
Capsular reactions of Cryptococcus neoformans with polyspecific and oligospecific polyclonal anticapsular antibodies.
Infection and immunity 2001;69(2):1189-91.
2001: Donatella Pietrella; Thomas R Kozel; Claudia Monari; Francesco Bistoni; Anna Vecchiarelli
Interleukin-12 counterbalances the deleterious effect of human immunodeficiency virus type 1 envelope glycoprotein gp120 on the immune response to Cryptococcus neoformans.
The Journal of infectious diseases 2001;183(1):51-8.
2000: Marta Feldmesser; J Rivera; Y Kress; Thomas R Kozel; Arturo Casadevall
Antibody interactions with the capsule of Cryptococcus neoformans.
Infection and immunity 2000;68(6):3642-50.
2000: Anna Vecchiarelli; Cinzia Retini; Donatella Pietrella; Claudia Monari; Thomas R Kozel
T lymphocyte and monocyte interaction by CD40/CD40 ligand facilitates a lymphoproliferative response and killing of Cryptococcus neoformans in vitro.
European journal of immunology 2000;30(5):1385-93.
2000: T C MacGill; Randall S MacGill; Arturo Casadevall; Thomas R Kozel
Biological correlates of capsular (quellung) reactions of Cryptococcus neoformans.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(9):4835-42.
1999: Donatella Pietrella; Claudia Monari; Cinzia Retini; B Palazzetti; Thomas R Kozel; Anna Vecchiarelli
HIV type 1 envelope glycoprotein gp120 induces development of a T helper type 2 response to Cryptococcus neoformans.
AIDS (London, England) 1999;13(16):2197-207.
1999: Claudia Monari; Thomas R Kozel; Arturo Casadevall; Donatella Pietrella; B Palazzetti; Anna Vecchiarelli
B7 costimulatory ligand regulates development of the T-cell response to Cryptococcus neoformans.
Immunology 1999;98(1):27-35.
1998: Mason X Zhang; Jim E Cutler; Y Han; Thomas R Kozel
Contrasting roles of mannan-specific monoclonal immunoglobulin M antibodies in the activation of classical and alternative pathways by Candida albicans.
Infection and immunity 1998;66(12):6027-9.
1998: Donatella Pietrella; Claudia Monari; Cinzia Retini; B Palazzetti; Thomas R Kozel; Anna Vecchiarelli
Cryptococcus neoformans and Candida albicans regulate CD4 expression on human monocytes.
The Journal of infectious diseases 1998;178(5):1464-71.
1998: J Mukherjee; Thomas R Kozel; Arturo Casadevall
Monoclonal antibodies reveal additional epitopes of serotype D Cryptococcus neoformans capsular glucuronoxylomannan that elicit protective antibodies.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(7):3557-68.
1998: Mason X Zhang; Thomas R Kozel
Mannan-specific immunoglobulin G antibodies in normal human serum accelerate binding of C3 to Candida albicans via the alternative complement pathway.
Infection and immunity 1998;66(10):4845-50.
1998: Anna Vecchiarelli; Cinzia Retini; Arturo Casadevall; Claudia Monari; Donatella Pietrella; Thomas R Kozel
Involvement of C3a and C5a in interleukin-8 secretion by human polymorphonuclear cells in response to capsular material of Cryptococcus neoformans.
Infection and immunity 1998;66(9):4324-30.
1998: Arturo Casadevall; Wendy Cleare; Marta Feldmesser; Aharona Glatman-Freedman; David Goldman; Thomas R Kozel; Nikoletta Lendvai; J Mukherjee; Liise-anne Pirofski; J Rivera; AL Rosas; Matthew D Scharff; Philippe Valadon; K Westin; Z Zhong
Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.
Antimicrobial agents and chemotherapy 1998;42(6):1437-46.
1998: Thomas R Kozel
Complement activation by pathogenic fungi.
Research in immunology 1998;149(4-5):309-20; discussion 514-5.
1998: Thomas R Kozel; Randall S MacGill; K K Wall
Bivalency is required for anticapsular monoclonal antibodies to optimally suppress activation of the alternative complement pathway by the Cryptococcus neoformans capsule.
Infection and immunity 1998;66(4):1547-53.
1998: Thomas R Kozel; B C deJong; M M Grinsell; Randall S MacGill; K K Wall
Characterization of anticapsular monoclonal antibodies that regulate activation of the complement system by the Cryptococcus neoformans capsule.
Infection and immunity 1998;66(4):1538-46.
1998: Cinzia Retini; Anna Vecchiarelli; Claudia Monari; Francesco Bistoni; Thomas R Kozel
Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes.
Infection and immunity 1998;66(2):664-9.
1997: Mason X Zhang; D M Lupan; Thomas R Kozel
Mannan-specific immunoglobulin G antibodies in normal human serum mediate classical pathway initiation of C3 binding to Candida albicans.
Infection and immunity 1997;65(9):3822-7.
1997: A C Savoy; D M Lupan; Pacita Manalo; J S Roberts; A M Schlageter; LC Weinhold; Thomas R Kozel
Acute lethal toxicity following passive immunization for treatment of murine cryptococcosis.
Infection and immunity 1997;65(5):1800-7.
1997: Y C Chang; R Cherniak; Thomas R Kozel; D L Granger; Laura C Morris; LC Weinhold; K J Kwon-Chung
Structure and biological activities of acapsular Cryptococcus neoformans 602 complemented with the CAP64 gene.
Infection and immunity 1997;65(5):1584-92.
1997: Stuart M Levitz; A Tabuni; Thomas R Kozel; Randall S MacGill; R R Ingalls; Douglas T Golenbock
Binding of Cryptococcus neoformans to heterologously expressed human complement receptors.
Infection and immunity 1997;65(3):931-5.
1997: T Belay; R Cherniak; Thomas R Kozel; Arturo Casadevall
Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay.
Infection and immunity 1997;65(2):718-28.
1996: Thomas R Kozel; L C Weinhold; D M Lupan
Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans.
Infection and immunity 1996;64(8):3360-8.
1996: Cinzia Retini; Anna Vecchiarelli; Claudia Monari; Carlo Tascini; Francesco Bistoni; Thomas R Kozel
Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils.
Infection and immunity 1996;64(8):2897-903.
1996: Anna Vecchiarelli; Cinzia Retini; Claudia Monari; Carlo Tascini; Francesco Bistoni; Thomas R Kozel
Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes.
Infection and immunity 1996;64(7):2846-9.
1996: Thomas R Kozel; A Tabuni; B J Young; Stuart M Levitz
Influence of opsonization conditions on C3 deposition and phagocyte binding of large- and small-capsule Cryptococcus neoformans cells.
Infection and immunity 1996;64(6):2336-8.
1996: Thomas R Kozel
Activation of the complement system by pathogenic fungi.
Clinical microbiology reviews 1996;9(1):34-46.
1995: Thomas R Kozel
Virulence factors of Cryptococcus neoformans.
Trends in microbiology 1995;3(8):295-9.
1995: Anna Vecchiarelli; Cinzia Retini; Donatella Pietrella; Claudia Monari; Carlo Tascini; Tommaso Beccari; Thomas R Kozel
Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes.
Infection and immunity 1995;63(8):2919-23.
1994: Arturo Casadevall; M DeShaw; M Fan; F Dromer; Thomas R Kozel; Liise-anne Pirofski
Molecular and idiotypic analysis of antibodies to Cryptococcus neoformans glucuronoxylomannan.
Infection and immunity 1994;62(9):3864-72.
1994: D C Houpt; G S Pfrommer; B J Young; T A Larson; Thomas R Kozel
Occurrences, immunoglobulin classes, and biological activities of antibodies in normal human serum that are reactive with Cryptococcus neoformans glucuronoxylomannan.
Infection and immunity 1994;62(7):2857-64.
1994: E W Otteson; William H Welch; Thomas R Kozel
Protein-polysaccharide interactions. A monoclonal antibody specific for the capsular polysaccharide of Cryptococcus neoformans.
The Journal of biological chemistry 1994;269(3):1858-64.
1994: R G Keller; G S Pfrommer; Thomas R Kozel
Occurrences, specificities, and functions of ubiquitous antibodies in human serum that are reactive with the Cryptococcus neoformans cell wall.
Infection and immunity 1994;62(1):215-20.
1993: G S Pfrommer; S M Dickens; M A Wilson; B J Young; Thomas R Kozel
Accelerated decay of C3b to iC3b when C3b is bound to the Cryptococcus neoformans capsule.
Infection and immunity 1993;61(10):4360-6.
1993: B J Young; Thomas R Kozel
Effects of strain variation, serotype, and structural modification on kinetics for activation and binding of C3 to Cryptococcus neoformans.
Infection and immunity 1993;61(7):2966-72.
1993: Thomas R Kozel
Opsonization and phagocytosis of Cryptococcus neoformans.
Archives of medical research 1993;24(3):211-8.
1993: Thomas R Kozel
Activation of the complement system by the capsule of Cryptococcus neoformans.
Current topics in medical mycology 1993;5():1-26.
1992: K Truelsen; T Young; Thomas R Kozel
In vivo complement activation and binding of C3 to encapsulated Cryptococcus neoformans.
Infection and immunity 1992;60(9):3937-9.
1992: Thomas R Kozel; M A Wilson; William H Welch
Kinetic analysis of the amplification phase for activation and binding of C3 to encapsulated and nonencapsulated Cryptococcus neoformans.
Infection and immunity 1992;60(8):3122-7.
1992: M A Wilson; Thomas R Kozel
Contribution of antibody in normal human serum to early deposition of C3 onto encapsulated and nonencapsulated Cryptococcus neoformans.
Infection and immunity 1992;60(3):754-61.
1992: K J Kwon-Chung; Thomas R Kozel; Jennifer C Edman; I Polacheck; D Ellis; T Shinoda; F Dromer
Recent advances in biology and immunology of Cryptococcus neoformans.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1992;30 Suppl 1():133-42.
1991: Thomas R Kozel; M A Wilson; J W Murphy
Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans.
Infection and immunity 1991;59(9):3101-10.
1990: J E Sanford; D M Lupan; A M Schlageter; Thomas R Kozel
Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide.
Infection and immunity 1990;58(6):1919-23.
1990: A M Schlageter; Thomas R Kozel
Opsonization of Cryptococcus neoformans by a family of isotype-switch variant antibodies specific for the capsular polysaccharide.
Infection and immunity 1990;58(6):1914-8.
1989: Thomas R Kozel; M A Wilson; T P Farrell; Stuart M Levitz
Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae.
Infection and immunity 1989;57(11):3412-7.
1989: C Spiropulu; R A Eppard; E Otteson; Thomas R Kozel
Antigenic variation within serotypes of Cryptococcus neoformans detected by monoclonal antibodies specific for the capsular polysaccharide.
Infection and immunity 1989;57(10):3240-2.
1989: Thomas R Kozel; M A Wilson; G S Pfrommer; A M Schlageter
Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins.
Infection and immunity 1989;57(7):1922-7.
1988: Thomas R Kozel; G S Pfrommer; A S Guerlain; B A Highison; G J Highison
Strain variation in phagocytosis of Cryptococcus neoformans: dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3.
Infection and immunity 1988;56(11):2794-800.
1988: Thomas R Kozel; G S Pfrommer; A S Guerlain; B A Highison; G J Highison
Role of the capsule in phagocytosis of Cryptococcus neoformans.
Reviews of infectious diseases 1988;10 Suppl 2():S436-9.
1988: Thomas R Kozel; C A Hermerath
Benzoquinone activation of Cryptococcus neoformans capsular polysaccharide for construction of an immunoaffinity column.
Journal of immunological methods 1988;107(1):53-8.
1987: Thomas R Kozel; G S Pfrommer; D Redelman
Activated neutrophils exhibit enhanced phagocytosis of Cryptococcus neoformans opsonized with normal human serum.
Clinical and experimental immunology 1987;70(1):238-46.
1987: Thomas R Kozel; R R Brown; G S Pfrommer
Activation and binding of C3 by Candida albicans.
Infection and immunity 1987;55(8):1890-4.
1986: Thomas R Kozel; G S Pfrommer
Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast.
Infection and immunity 1986;52(1):1-5.
1984: Thomas R Kozel; C A Hermerath
Binding of cryptococcal polysaccharide to Cryptococcus neoformans.
Infection and immunity 1984;43(3):879-86.